1. "Carol Aghajanian"
  2. "Lippincott Williams & Wilkins"
Formats
  1. Meeting Abstract (25)
  2. Journal Article (22)
Groups
  1. Department of Medicine (47)
  2. GDMT, Medicine (47)
  3. Gynecologic Medicine Service (47)
  4. Gynecology Disease Management Team (47)
  5. Solid Tumor Oncology Division (47)
  6. Epidemiology and Biostatistics (18)

More Groups

People
  1. Carol Aghajanian (47)
  2. Alexia Iasonos (14)
  3. Nadeem Abu-Rustum (10)
  4. Paul Sabbatini (10)
  5. Qin Zhou (10)
  6. David Spriggs (9)

More People

Years
  1. 2022 (7)
  2. 2021 (2)
  3. 2020 (6)
  4. 2019 (7)
  5. 2018 (3)
  6. 2017 (2)

More Years

Publications
  1. International Journal of Gynecological Cancer (45)
  2. American Journal of Surgical Pathology (1)
  3. Current Opinion in Oncology (1)
Publishers
  1. Lippincott Williams & Wilkins (47)

Results (47)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic instability as a determinant of immune escape in ovarian cancer
    Meeting Abstract

    Vazquez-Garcia, I.; Uhlitz, F.; Ceglia, N.; Lim, J.; Wu, M.; Mohibullah, N.; Niyazov, J.; Ruiz, A. E.; Soslow, R.; Ellenson, L.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Olaparib treatment in patients with platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Characterization of long-term/short-term treatment duration in light
    Meeting Abstract

    Liu, Y.; Mathews, C.; Simpkins, F.; Cadoo, K.; Provencher, D.; McCormick, C.; Einaggar, A.; Altman, A.; Gilbert, L.; Black, D.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Germline pathogenic variants in DNA repair genes and endometrial cancer risk
    Meeting Abstract

    Gordhandas, S.; Rios-Doria, E.; Cadoo, K.; Catchings, A.; Maio, A.; Kemel, Y.; Manning-Geist, B.; Sia, T.; Roche, K. L.; Leitao, M.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Molecular stratification of ovarian clear cell carcinoma predicts clinical outcomes
    Meeting Abstract

    Gordhandas, S.; Manning-Geist, B.; Hodgson, A.; Zhou, Q.; Iasonos, A.; Chi, D.; Momeni-Boroujeni, A.; Abu-Rustum, N.; Leitao, M.; Roche, K. L.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study
    Meeting Abstract

    Gien, L.; Enserro, D.; Block, M.; Waggoner, S.; Duska, L.; Hendrickson, A. W.; Thaker, P.; Backes, F.; Bottsford-Miller, J.; Muller, C.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Overall survival results from Ariel3: A phase 3 randomized, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma
    Meeting Abstract

    Coleman, R. L.; Oza, A.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J.; Clamp, A.; Scambia, G.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Management of patients with early-stage ovarian clear cell carcinoma: Risk stratification and fertility conservation
    Journal Article

    Manning-Geist, B.; Gordhandas, S.; Hodgson, A.; Zhou, Q. C.; Iasonos, A.; Chi, D. S.; Ellenson, L.; Aghajanian, C. A.; Abu-Rustum, N. R.; Leitao, M.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian cancer (HGOC)
    Meeting Abstract

    Coleman, R. L.; Oza, A.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J.; Clamp, A.; Scambia, G.; more...
    International Journal of Gynecological Cancer (2021)

    Fulltext@MSK | Save
  • Rucaparib maintenance treatment for recurrent ovarian carcinoma: The effects of progression-free interval and prior therapies on efficacy and safety in the randomized phase III trial ARIEL3
    Journal Article

    Clamp, A. R.; Lorusso, D.; Oza, A. M.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Scambia, G.; Leary, A.; more...
    International Journal of Gynecological Cancer (2021)

    Fulltext@MSK | Save
  • Distant metastatic spread and clonal evolution of high-grade endometrial cancers
    Meeting Abstract

    Miller, K.; Selenica, P.; Reis-Filho, J.; Abu-Rustum, N. R.; Makker, V.; Aghajanian, C. A.; Iacobuzio-Donahue, C. A.; Murali, R.; Weigelt, B.
    International Journal of Gynecological Cancer (2020)

    Fulltext@MSK | Save